Posted on May 25, 2010 by Sitemaster
A new study has shown that the generically available, oral, bisphosphonate risedronate (Actonel) can prevent bone loss and related effects in patients receiving hormonal therapy for prostate cancer. … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: bisphosphonate, bone, hormone, loss, risedronate, therapy, turnover | Leave a comment »
Posted on July 8, 2009 by Sitemaster
Today’s prostate cancer news reports cover items on:
- Assessment of quality of life after radical prostatectomy
- Permanent seed brachytherapy in treatment of localized disease
- Cryotherapy in treatment of patients with Gleason 8-10 localized disease
- Actonel and/or estradiol in prevention of SREs … READ MORE …
Filed under: Living with Prostate Cancer, Management, Treatment | Tagged: Actonel, brachytherapy, cryotherapy, estradiol, Gleason score, outcome, permanent, quality of life, risedronate, seed, survey | Leave a comment »
THE "NEW" PROSTATE CANCER INFOLINK 